Embryo Ventures

Embryo Ventures is a London-based early-stage venture capital firm founded in 2019 by Arash Moavenian, backing exceptional founders building at the frontiers of human progress. The firm invests in companies at the intersection of health, cities, and living, spanning consumer, industrial, and healthcare products and platforms. Its geographic reach covers more than 20 European countries as well as the United States and Israel, with a primary concentration in the United Kingdom. Embryо invests at Pre-seed and Seed stages with check sizes from $10,000 to $1 million, and has made 16 investments across healthtech, deep tech, sustainable technology, clean technology, SaaS, and hardware. Notable portfolio companies include Osstec in therapeutic medical devices, Gladys in elder care technology, and Bridgefy, a communication software platform. The firm operates with a thesis that sustainable development across health, urban environments, and living patterns represents one of the most important frontiers for venture-backed innovation. Embryо Ventures is committed to being an active partner and delivers value well beyond capital, focusing on companies that address meaningful societal needs and drive positive, sustainable change globally. Moavenian's founding vision emphasizes close collaboration with founders on strategy, networks, and operational challenges from the earliest stages, positioning the firm as a conviction-led first-check backer in the European frontier technology ecosystem.